Amrinone‐Mediated Thrombocytopenia

Evlin L. Kinney, James O. Ballard, Brian Carlin, Robert Zelis

Research output: Contribution to journalArticle

15 Scopus citations


Amrinone, a new cardioactive drug, was administered for, on average, 27.9 d to 12 patients in severe congestive heart failure. Thrombocytopenia occurred in 4 patients, while a progressive decline in platelet numbers developed in 3 additional patients. The mechanism for these adverse effects of amrinone is unclear, but merits further study because of its frequency.

Original languageEnglish (US)
Pages (from-to)376-380
Number of pages5
JournalScandinavian Journal of Haematology
Issue number4
StatePublished - Oct 1983


All Science Journal Classification (ASJC) codes

  • Hematology

Cite this